Author contributions
Di Jing and Liting Shi conceived of the presented idea and supervised the project. Kang Ren, Lin Shen, Minwu Yang, Xuan Long, Tingyin Chen, and Hao-Yuan She prepared the sample and collected the data. Kui Sun, Kang Ren and Di Jing defined the regions of interest and assessed treatment response and Hematologic Toxicities. Liangfang Shen examined treatment response. Lin Shen, Lan Deng, and Liting Shi organized the data and calculated the radiomics features. Liting Shi and Jianfeng Qiu designed the computational model and analyzed the data. Kang Ren, Lin Shen, Di Jing and Liting Shi wrote the manuscript. All authors provided critical feedback and helped shape the analysis and manuscript.
Ethics approval
Ethical approval was granted by The ethics committee of Xiangya Hospital granted ethical approval on November 27, 2020. The informed consent obtained from all patients.